MedPath

Janssen-Cilag Manufacturing, LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

4

NMPA:4

Drug Approvals

Methylphenidate Hydrochloride Prolonged-Release Tablets

Product Name
专注达
Approval Number
J20171050
Approval Date
Aug 31, 2017
NMPA

Methylphenidate Hydrochloride Prolonged-Release Tablets

Product Name
专注达
Approval Number
国药准字J20171049
Approval Date
Aug 31, 2017
NMPA

Methylphenidate Hydrochloride Prolonged-Release Tablets

Product Name
专注达
Approval Number
国药准字J20171050
Approval Date
Aug 31, 2017
NMPA

Methylphenidate Hydrochloride Prolonged-Release Tablets

Product Name
专注达
Approval Number
J20171049
Approval Date
Aug 31, 2017
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.